An industry is prescribing weight-loss drugs to people with anorexia, devastating lives

CNN investigates the misuse of GLP-1 weight-loss drugs by individuals suffering from anorexia nervosa. The report highlights how easily accessible telehealth platforms are enabling patients with eating disorders to obtain these medications without adequate medical oversight.
Why it matters
It exposes a critical safety gap in the telehealth industry that is exacerbating life-threatening mental health conditions.
For AJ Jasper, drugs hailed as miracles have proven nothing short of a curse. In 2024, a hard-won truce between Jasper and the anorexia he had battled, on and off, since childhood collapsed, sending him spiraling to his lowest ebb yet. He was only a few pounds below his target weight, but a stressful period compelled Jasper to seek out a new, revolutionary class of weight-loss medication. Jasper said he submitted a form to the telehealth site Hims & Hers, lying about his weight and asking for a GLP-1 prescription. He expected to speak to a doctor. For there to be more questions. Yet in about two days, the medication was at his door. “I thought that there would be roadblocks,” he told CNN from his apartment in Chicago.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in